Stage III Bladder Urothelial Carcinoma
5 clinical trials · Condition
◉ Watch Stage III Bladder Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations (NCT03609216) | Alliance for Clinical Trials in Oncology | 2018-12-10 |
| Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery (NCT02944357) | Mayo Clinic | 2016-11-01 |
| Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer (NCT02699853) | University of Southern California | 2016-04-12 |
| Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer (NCT02494635) | University of Southern California | 2015-09-16 |
| Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer (NCT02437370) | University of California, Davis | 2015-09-01 |
Track Stage III Bladder Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.